Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases

Cardiovascular and metabolic disease (CMD) remains a main cause of premature death worldwide. Berberine (BBR), a lipid-lowering botanic compound with diversified potency against metabolic disorders, is a promising candidate for ameliorating CMD. The liver is the target of BBR so that liver-site accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hui-Hui, Feng, Chen-Lin, Zhang, Wen-Xuan, Luo, Zhi-Gang, Zhang, Hong-Juan, Zhang, Ting-Ting, Ma, Chen, Zhan, Yun, Li, Rui, Wu, Song, Abliz, Zeper, Li, Cong, Li, Xiao-Lin, Ma, Xiao-Lei, Wang, Lu-Lu, Zheng, Wen-Sheng, Han, Yan-Xing, Jiang, Jian-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491597/
https://www.ncbi.nlm.nih.gov/pubmed/31040273
http://dx.doi.org/10.1038/s41467-019-09852-0

Ejemplares similares

Ejemplares similares